Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up-Reference-Cited by-同舟云学术

Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up

Published:2022-09 Issue:3 Volume:163 Page:754-756.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ford Alexander C.^ORCID,Yuan Yuhong,Moayyedi Paul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

2. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

3. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

4. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023);Journal of Pediatric Gastroenterology and Nutrition;2024-08-15

2. Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial;Nature Medicine;2024-07-30

4. Maintaining H. pylori Negativity After Eradication Can Consolidate Its Benefit in Gastric Cancer Prevention: A Meta-Analysis;Clinical and Translational Gastroenterology;2024-07-02

5. An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota;Acta Pharmaceutica Sinica B;2024-07